Failure2Fortune: Unveiling Success's Hidden Pathways
Innovation needs failure. All progress, not only technological progress, is built on learning from past failures and mistakes. Behind every success lie several significant failures – is it just a cliché or is it a fact?
Failure2Fortune is a community where invited guests share important failures that have led to increased knowledge, courage and resilience. A community for researchers, startups, and others working in or are interested in exploring the field of medical technology. This time we are proud to present Sofia Mayans and Helena Fordell!
Date: 5/9
Time: 17.00-19.30
Location: A Working Lab, Universums gränd 8, 907 36 Umeå
Language: English
Cost: The event is free to attend.
We offer a light meal, so please indicate any allergies or dietary preferences when you register.
Join us for a gathering where failure is not just accepted, it’s celebrated!
Failure2Fortune is a concept by Medtech4Health, a national innovation program with the mission to enable the implementation of new innovations in health and social care.
On stage
Sofia Mayans
Sofia Mayans is a seasoned professional with over 8 years of experience as CEO at InfiCure Bio AB, specializing in the development of anti-fibrotic drugs to combat organ failure. Currently serving as acting CEO at Vakona AB and Senior Innovation and Business Advisor at SLU Holding, she brings expertise in business strategy, project management, and client relations to her roles, bolstered by her extensive background in life sciences and research. With a track record of leadership and innovation, Sofia continues to drive impactful solutions in the fields of fibrosis research and drug development.
Helena Fordell
Helena Fordell is a neurologist, researcher and founder of Brain Stimulation AB, a spin-off SME company from UMU. A company built on her successful research results, using Mixed Reality, as a platform to apply knowledge of brain-plasticity, to create engaging and restorative rehabilitation program with interactive 3D holograms. Helena has more than 20 years of experience working in the borderland as a researcher and entrepreneur, she was awarded the SKAPA Prize in 2017. The products are now available for clinical use, and she continue to publish results from international collaborations. Multicenter trials are ongoing in close collaboration with Oxford University, and other leading academic institutes. She also has a strong commitment, both nationally and internationally, to supporting female researchers in multi-disciplinary translational research.
